Your session is about to expire
← Back to Search
Bronchoscopy for Lung Cancer
N/A
Recruiting
Led By Peter Kneuertz, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Computed tomography (CT)-scan finding suspicious for lung cancer with nodal metastases
Clinically stable to undergo diagnostic workup by bronchoscopy with endobronchial ultrasound
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
Study Summary
This trial is testing how well a needle aspiration guided by endobronchial ultrasound works in getting samples from patients suspected to have lung cancer that has spread to the nodules.
Eligible Conditions
- Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of samples collected via endobronchial ultrasound-guided transbronchial needle-aspiration with suction
Side effects data
From 2020 Phase 2 trial • 28 Patients • NCT022301895%
Pregnancy identified during study enrollment
5%
Increased systolic blood pressure post-bronchoscopy
5%
Respiratory infection post-bronchoscopy
100%
80%
60%
40%
20%
0%
Study treatment Arm
Allergic Asthmatics(AA)
Allergic Non-Asthmatics(ANA)
Non-Allergic Non-Asthmatics(NANA)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic (bronchoscopy with EBUS-TBNA with/without vacuum)Experimental Treatment2 Interventions
Patients undergo bronchoscopy with EBUS-TBUA first without and then with applied vacuum.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bronchoscopy
2002
Completed Phase 2
~2270
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
316 Previous Clinical Trials
289,423 Total Patients Enrolled
Peter Kneuertz, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants have been recruited to take part in this research?
"Indeed, the research posted on clinicaltrials.gov affirms that this trial is currently recruiting participants. It was first announced on August 31st 2020 and its latest update occurred June 13th 2022; 263 patients are required to be enrolled at a single site."
Answered by AI
Is there still capacity available to enroll in this trial?
"According to clinicaltrials.gov, this research project is recruiting volunteers at present. The protocol was originally published on August 31st 2020 and experienced its most recent amendment on June 13th 2022"
Answered by AI
Share this study with friends
Copy Link
Messenger